ADVFN - Advanced Financial Network.
HOME» NYSE » M » MRK Stock Price » MRK Stock News

Merck Share News

 Merck & Co., Stock Price
MRK Stock Price
 Merck & Co., Stock Chart
MRK Stock Chart
 Merck & Co., Stock News
MRK Stock News
 Merck & Co., Company Information
MRK Company Information
 Merck & Co., Stock Trades
MRK Stock Trades

Merck in Talks to Buy Indian Pharmaceutical Ingredients Maker Micro Labs - Report

Merck & Co. Inc. (MRK) is in talks to acquire Indian active pharmaceutical ingredients maker Micro Labs Ltd., the Financial Express reported Thursday, citing an unidentified person aware of the matter. The newspaper said Bangalore-based Micro Labs is a privately held company, founded and run by the Surana family. Micro Labs aims to achieve sales of about $1 billion by 2015, the report said, citing the company's website. A Merck India spokesperson declined to comment to the newspaper on any possible deal. Newspaper website: http://www.financialexpress.com Write to djn.in@dowjones.com

Stock News for Merck (MRK)
DateTimeHeadline
06/29/201607:00:00Merck & Moderna Announce Strategic Collaboration to Advance Novel...
06/27/201606:00:00Merck Receives CHMP Positive Opinion for KEYTRUDA® (pembrolizumab...
06/24/201608:00:00Merck to Hold Second-Quarter 2016 Sales and Earnings Conference...
06/22/201611:50:00MARKET SNAPSHOT: U.S. Stocks Try To Extend Gains To 3rd Day Ahead...
06/20/201612:30:00Results of Phase 2 Study of Merck’s Investigational Beta-Lactamase I...
06/17/201613:35:56Annual Report of Employee Stock Plans (11-k)
06/17/201613:34:56Annual Report of Employee Stock Plans (11-k)
06/17/201613:33:19Annual Report of Employee Stock Plans (11-k)
06/16/201617:08:00MARKET SNAPSHOT: Stocks Snap 5-day Losing Streak; Dow Reverses...
06/16/201616:37:00MARKET SNAPSHOT: Stocks Snap 5-day Losing Streak; Dow Reverses...
06/16/201612:44:00MARKET SNAPSHOT: U.S. Stocks Fall As Investors Worry About Brexit...
06/16/201611:09:00MARKET SNAPSHOT: U.S. Stocks Head For 6th Daily Drop Amid Global...
06/16/201610:00:00MARKET SNAPSHOT: Dow Industrials Drop 113 Points As Brexit Fears...
06/16/201608:00:00Systematic Review of 58 Publications of Real-World Use of GARDASIL®...
06/16/201606:45:00Merck’s KEYTRUDA® (pembrolizumab) Demonstrates Superior Progression-Free & O...
06/15/201608:30:00Merck Highlights Ongoing Commitment to Fighting Infectious Diseases...
06/14/201602:00:00New Data From GAP Landmark Trial Confirm GRAZAX® Significantly...
06/13/201611:00:00New Data From GAP Landmark Trial Confirm GRAZAX® Prevents Asthma...
06/13/201610:30:00Merck’s Investigational Insulin Glargine, MK-1293, Met Primary E...
06/11/201611:00:00Merck & Pfizer Announce Two Pivotal Phase 3 Studies for Ertugliflozin...

Merck and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad